- Previous Close
1.9350 - Open
1.9500 - Bid 1.9350 x --
- Ask 1.9550 x --
- Day's Range
1.9000 - 1.9500 - 52 Week Range
1.7050 - 2.6000 - Volume
12,638 - Avg. Volume
32,252 - Market Cap (intraday)
166.33M - Beta (5Y Monthly) 1.37
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0700 - Earnings Date Feb 27, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
EMVision Medical Devices Ltd engages in the research, development, and commercialization of neurodiagnostic technology for stroke diagnosis and monitoring, and other medical imaging needs in Australia. The company offers non-invasive brain scanners bedside device emu, an ultra-light weight first responder pre-hospital device. EMVision Medical Devices Ltd was incorporated in 2017 and is based in Macquarie Park, Australia.
www.emvision.com.auRecent News: EMV.AX
View More
Performance Overview: EMV.AX
Trailing total returns as of 4/2/2025, which may include dividends or other distributions. Benchmark is S&P/ASX 200 [XJO] (^AXJO) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: EMV.AX
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: EMV.AX
View MoreValuation Measures
Market Cap
166.33M
Enterprise Value
154.91M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
10.80
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-76.77%
Return on Assets (ttm)
-23.79%
Return on Equity (ttm)
-58.61%
Revenue (ttm)
8.06M
Net Income Avi to Common (ttm)
-6.19M
Diluted EPS (ttm)
-0.0700
Balance Sheet and Cash Flow
Total Cash (mrq)
13.61M
Total Debt/Equity (mrq)
18.26%
Levered Free Cash Flow (ttm)
-6.08M